Aethlon Medical, Inc.
Aethlon Medical Announces ''First-In-Man'' HIV/AIDS Treatment Study
Published in Medicine and Law Weekly, July 18th, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) announced that it has entered into an agreement to initiate the "first-in-man" clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical device created to provide real-time therapeutic filtration of infectious viruses and immunosuppressive proteins. The Hemopurifier(R) holds promise to extend the lives of AIDS patients by removing HIV strains that cause drug failure and reducing the presence of viral proteins that kill-off immune cells. The clinical study was approved by the Institutional Ethics Committee at the Jattinder Gambhir...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Addiction Medicine
Study results from Karolinska Institut, Department of Clinical Neuroscience provide new insights into addiction medicine in adolescents - Aggression
New aggression study findings recently were reported by researchers at American University - Autopsy
Data from University of Hamburg advance knowledge in autopsy - Behavior
Research from M.T. Baker and co-authors reveals new findings on behavior - Dementia
Research from E.D. Abbo and co-researchers in the area of dementia published - Depression
Researchers at Brandeis University target depression - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
